Stock OCULUS INNOVATIVE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Oculus Innovative Sciences, Inc. Nasdaq

Equities

US67575P2074

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Oculus Innovative Sciences, Inc.
Feb. 08 Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Jan. 23 Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Initiates Coverage on Sonoma Pharmaceuticals at Buy, $3.25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. Stock
  5. News Oculus Innovative Sciences, Inc.
  6. Analyst Reco.